A Differentiated Cannabis Investment Opportunity
Emblem proved itself to be one of the most successful IPOs in 2016 and during this engaging discussion, you will learn how it is positioned to capitalize on the burgeoning Canadian cannabis industry. Emblem has been able to differentiate itself from other Canadian licensed medical cannabis producers through its attractive business model, proven management team, and high-quality products. Danny Brody, Emblem's director of investor relations, will provide a thorough breakdown of its unique value proposition that will make this a presentation you do not want to miss!
Canada Is Leading the Global Cannabis Revolution
When looking at the potential catalysts for the Canadian cannabis industry, none is more significant than the legalization of recreational cannabis at the federal level. This development will serve as a catalyst to the entire cannabis industry and this panel of licensed medical cannabis producers will discuss how they are in position to capitalize on the burgeoning cannabis industry.